APA (7th ed.) Citation

Yang, A., Yan, X., Fan, X., Shi, Y., Huang, T., Li, W., . . . You, H. (2021). Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice. Hepatology international, 15(5), 1122-1135. https://doi.org/10.1007/s12072-021-10210-w

Chicago Style (17th ed.) Citation

Yang, Aiting, Xuzhen Yan, Xu Fan, Yiwen Shi, Tao Huang, Weiyu Li, Wei Chen, Jidong Jia, and Hong You. "Hepatic Stellate Cells-specific LOXL1 Deficiency Abrogates Hepatic Inflammation, Fibrosis, and Corrects Lipid Metabolic Abnormalities in Non-obese NASH Mice." Hepatology International 15, no. 5 (2021): 1122-1135. https://doi.org/10.1007/s12072-021-10210-w.

MLA (9th ed.) Citation

Yang, Aiting, et al. "Hepatic Stellate Cells-specific LOXL1 Deficiency Abrogates Hepatic Inflammation, Fibrosis, and Corrects Lipid Metabolic Abnormalities in Non-obese NASH Mice." Hepatology International, vol. 15, no. 5, 2021, pp. 1122-1135, https://doi.org/10.1007/s12072-021-10210-w.